Precision BioSciences, Inc.
DTIL
$7.43
$0.131.78%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 32.62% | -98.31% | -737.98% | -1,069.52% | -561.16% |
| Total Depreciation and Amortization | -18.11% | -30.27% | -39.85% | -47.32% | -50.49% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 525.37% | 395.00% | 139.36% | 184.23% | 130.14% |
| Change in Net Operating Assets | -514.77% | 3.32% | 45.84% | 97.82% | 109.24% |
| Cash from Operations | 18.80% | -0.36% | -12.66% | -52.07% | 2.22% |
| Capital Expenditure | 81.68% | 82.89% | 66.00% | -28.35% | 57.38% |
| Sale of Property, Plant, and Equipment | 1,220.00% | -- | 10.00% | -77.32% | -94.85% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -55.17% | -69.09% | -2,360.00% | -103.33% | -103.66% |
| Cash from Investing | 13.55% | 13.72% | -194.88% | -434.21% | -106.45% |
| Total Debt Issued | -- | -- | -- | -100.09% | -- |
| Total Debt Repaid | -- | -- | -- | 100.00% | -- |
| Issuance of Common Stock | 211.25% | 304.29% | 88.49% | -50.21% | -41.14% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 211.70% | 305.00% | 88.63% | -50.24% | -41.18% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 171.20% | 168.62% | 449.39% | -5,449.94% | -172.55% |